CA22617-2 - 0x00000000000035A7

Study Number: CA22617
Group Number: 2
Study Requirement: Healthy Normal Male and Female
Stipend: up to £ 1,059

Study Criteria:

  • Age: 18 - 55
  • BMI: 0 - 0
  • Weight Restriction: minimum weight 0 lbs

Study Information:

  • Indication: This investigational medication is being developed as a vaccine for Chikungunya infection.
  • Route of Administration: Injection intramuscular
  • Blood Draws: 8

Study Schedule:

  • Schedule Type: Return Only
  • Study Length: 7 Returns

Screening Dates:

Event Day Event Date Site
No search results

Doctor Exam Dates:

Event Day Event Date Site
No search results

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Return Monday Oct 8 2018 7:00AM Monday Oct 8 2018 2:30PM 1 Belfast
Return Monday Oct 22 2018 8:30AM Monday Oct 22 2018 12:30PM 1 Belfast
Return Monday Nov 5 2018 7:00AM Monday Nov 5 2018 2:30PM 1 Belfast
Return Monday Nov 19 2018 8:30AM Monday Nov 19 2018 12:30PM 1 Belfast
Return Monday Dec 3 2018 8:30AM Monday Dec 3 2018 1:00PM 1 Belfast
Return Monday Apr 8 2019 8:30AM Monday Apr 8 2019 12:30PM 1 Belfast
Return Monday Oct 7 2019 8:30AM Monday Oct 7 2019 1:00PM 1 Belfast